00:01
Drug-induced thrombocytopenia.
00:02
If you missed our discussion on heparin,
please make sure that you refer to our hematology hemodynamic pharmacology
where I talked about in great detail the possibility when given heparin at the site of injection
where there's a possibility in sub-set of population
in which may then activate the platelet via platelet factor IV.
00:21
And by doing so, you may then form a thrombi formation and result in thrombocytopenia.
00:25
Other causes, quinidine class 1A sodium-channel blocker, sulphas, methyldopa.
00:32
That'll be in alpha 2 agonist that you may then give a pregnant lady who has hypertension prior,
was on ACE inhibitor, obviously, needs to remove that, right?
Because ACE inhibitor will kill the kidneys of the fetus or teratogen.
00:45
And unfortunate the patient may then develop thrombocytopenia.
00:50
Also penicillins and also thiazide diuretics.
00:55
HIV-associated thrombocytopenia.
01:00
This is important.
01:01
So now you have antibodies formed against HIV antigen.
01:05
The gp120 cross-react with the platelet surface antigen.
01:11
In other words, we have example of molecular mimicry of IIb/IIIa.
01:15
Unbelievable.
01:16
And now what happens is the antibodies bind to the platelet which are then cleared by the spleen.
01:23
The particular antigen or chemokine receptor that you
wanna know that allows for entry of HIV in the platelet,
if you remember from microbiology it's called CXCR4.
01:32
Keep that in mind please.
01:34
But at this point, in pathology with HIV, take a look at molecular mimicry with gp120
if you remember that from your HIV discussion.